Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
Published date:
10/05/2021
Excerpt:
Ganitumab was tested in combination with metformin and paclitaxel (PGM)...In the HR-negative/HER2-negative subtype, pCR rates were higher in the arm compared to control…